Auro Labs, a company in the Pharmaceuticals industry, reported revenue of ₹14 crore and net profit of ₹1.17 crore for the September 2026 quarter.
Auro Labs. (BSE: AUROLAB) closed at ₹248.75 on 20 Nov 2026, down 3.6% over the past year. Its market capitalisation is ₹155 crore and it trades at 29.6 times earnings.
Incorporated in 1989, Auro Laboratories Ltd is in the business of Bulk Drugs
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.